Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment

door Fruci, Barbara, Giuliano, Stefania, Mazza, Angela, Malaguarnera, Roberta, Belfiore, Antonino
Gepubliceerd in 2013

The Role of Metformin in the Management of NAFLD

door Mazza, Angela, Fruci, Barbara, Garinis, Giorgia Anna, Giuliano, Stefania, Malaguarnera, Roberta, Belfiore, Antonino
Gepubliceerd in 2012

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis

door Vella, Veronica, Nicolosi, Maria Luisa, Giuliano, Stefania, Bellomo, Maria, Belfiore, Antonino, Malaguarnera, Roberta
Gepubliceerd in Front Endocrinol (Lausanne) (2017)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes

door Mirabelli, Maria, Chiefari, Eusebio, Tocci, Vera, Caroleo, Patrizia, Giuliano, Stefania, Greco, Emanuela, Luque, Raul Miguel, Puccio, Luigi, Foti, Daniela Patrizia, Aversa, Antonio, Brunetti, Antonio
Gepubliceerd in J Clin Med (2021)

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes

door Mirabelli, Maria, Chiefari, Eusebio, Caroleo, Patrizia, Arcidiacono, Biagio, Corigliano, Domenica Maria, Giuliano, Stefania, Brunetti, Francesco Saverio, Tanyolaç, Sinan, Foti, Daniela Patrizia, Puccio, Luigi, Brunetti, Antonio
Gepubliceerd in Int J Environ Res Public Health (2019)